tiprankstipranks
Trending News
More News >
Lifestance Health Group (LFST)
NASDAQ:LFST
US Market

Lifestance Health Group (LFST) Earnings Dates, Call Summary & Reports

Compare
137 Followers

Earnings Data

Report Date
Aug 06, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
-0.02
Last Year’s EPS
-0.06
Same Quarter Last Year
Based on 6 Analysts Ratings

Earnings Call Summary

Earnings Call Date:May 07, 2025
|
% Change Since: -10.99%
|
Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Positive
LifeStance Health reported a solid start to 2025, exceeding guided metrics and achieving positive net income for the first time. The company showed strong clinician growth, improved operational efficiencies, and a significant improvement in free cash flow. However, pressures on revenue per visit and the competitive environment for recruiting clinicians present challenges. Overall, the positive aspects of the earnings call outweigh the negatives, indicating a strong performance and outlook.
Company Guidance
In the first quarter of 2025, LifeStance Health surpassed its financial guidance, reporting a robust performance across several metrics. They achieved a double-digit adjusted EBITDA margin of 10.4%, marking an improvement over expectations, and recorded positive net income for the first time since becoming a public company. The company also reported a solid revenue growth of 11% year-over-year, reaching $333 million, driven by a 10% increase in visit volumes to 2.1 million, primarily due to a 10% growth in their clinician base, now totaling 7,535 clinicians. Total revenue per visit rose by 1% to $159. Furthermore, LifeStance improved its free cash flow by $17 million compared to the same period last year, although it was still negative $10 million. They maintained strong leverage ratios with net leverage at 1.2x and gross leverage at 2.3x, significantly improved from the prior year's figures. Looking ahead, they are confident in their full-year guidance ranges, expecting revenues of $1.4 billion to $1.44 billion, center margin between $440 million to $464 million, and adjusted EBITDA ranging from $130 million to $150 million.
Exceeded Guided Metrics
LifeStance Health exceeded each of its guided metrics for the first quarter of 2025, instilling confidence in their ability to deliver on full-year guidance.
Solid Financial Performance
Reported revenue of $333 million, representing an 11% year-over-year growth, with double-digit adjusted EBITDA margins of 10.4%.
Positive Net Income
Achieved positive net income for the first time in LifeStance's history as a public company, with net income of $700,000.
Clinician Growth
Increased clinician base by 152 clinicians or 10% year-over-year, bringing the total to 7,535 clinicians.
Operational Excellence
Completed the rollout of the digital patient check-in tool, driving higher patient satisfaction, operational efficiencies, and significant improvements in patient collections.
Strong Free Cash Flow Improvement
Improved free cash flow by $17 million year-over-year in the first quarter, despite being negative $10 million.

Lifestance Health Group (LFST) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

LFST Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 06, 2025
2025 (Q2)
-0.02 / -
-0.06
May 07, 2025
2025 (Q1)
-0.03 / 0.00
-0.06
Feb 27, 2025
2024 (Q4)
-0.04 / -0.01
-0.1291.67% (+0.11)
Nov 07, 2024
2024 (Q3)
-0.07 / -0.02
-0.1788.24% (+0.15)
Aug 08, 2024
2024 (Q2)
-0.07 / -0.06
-0.1353.85% (+0.07)
May 09, 2024
2024 (Q1)
-0.08 / -0.06
-0.0933.33% (+0.03)
Feb 28, 2024
2023 (Q4)
-0.09 / -0.12
-0.137.69% (+0.01)
Nov 08, 2023
2023 (Q3)
-0.07 / -0.17
-0.11-54.55% (-0.06)
Aug 09, 2023
2023 (Q2)
-0.08 / -0.13
-0.1931.58% (+0.06)
May 10, 2023
2023 (Q1)
-0.09 / -0.09
-0.1850.00% (+0.09)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

LFST Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 07, 2025
$6.55$5.51-15.88%
Feb 27, 2025
$7.51$7.74+3.06%
Nov 07, 2024
$7.13$7.68+7.71%
Aug 08, 2024
$5.51$5.93+7.62%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Lifestance Health Group (LFST) report earnings?
Lifestance Health Group (LFST) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
    What is Lifestance Health Group (LFST) earnings time?
    Lifestance Health Group (LFST) earnings time is at Aug 06, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is LFST EPS forecast?
          LFST EPS forecast for the fiscal quarter 2025 (Q2) is -0.02.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis